Alloimmunization after granulocyte transfusions

Transfusion

Volumn 36, Issue 11-12, 1996, Pages 1009-1015

  Stroncek, D F ^a,b   Leonard, K ^c   Eiber, G ^d   Malech, H L ^e   Gallin, J I ^c   Leitman, S F ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d AMERICAN RED CROSS   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; FC RECEPTOR; HLA ANTIGEN; LEUKOCYTE ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ARTICLE; BLOOD TRANSFUSION REACTION; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; FEMALE; GRANULOCYTE TRANSFUSION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LYMPHOCYTOTOXICITY; MALE; NEUTROPENIA; RECIPIENT;

EID: 0029838028     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36111297091747.x     Document Type: Article

References (33)

1. Herzig RH, Herzig GP, Graw RG Jr, et al. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med 1977;296:701-5.
2. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977;63:548-55.
3. Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977;296:706-11.
4. Bhatia S, McCullough J, Perry EH, et al. Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion 1994;34:226-32.
5. Strauss RG, Connett JE, Gale RP, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 1981;305:597-603.
6. Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood 1978;52:323-31.
7. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
8. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-71.
9. Schiffer CA, Lictenfeld JL, Wiernik PH, et al. Antibody response in patients with acute nonlymphocytic leukemia. Cancer 1976;37:2177-82.
10. Howard JE, Perkins HA. The natural history of alloimmunization to platelets. Transfusion 1978;18:496-503.
11. Pagels JG, Brnynes ECE, Engelfriet CP, von dem Borne AE. Serological studies in patients on platelet and granulocyte substitution therapy. Br J Haematol 1982;52:59-68.
12. Schiffer CA, Aisner J, Daly PA, et al. Alloimmunization following prophylactic granulocyte transfusion. Blood 1979;54:766-74.
13. Holohan TV, Terasaki PI, Deisseroth AB. Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood 1981;58:122-8.
14. McCullough J, Clay M, Hurd D, et al. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood 1986;67:522-8.
15. Dutcher JP, Schiffer CA, Johnston GS, et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 1983;62:354-60.
16. Stroncek DF, Herr GP, Maguire RB, et al. Characterization of the neutrophil molecules identified by quinine-dependent antibodies from two patients. Transfusion 1994;34:980-5.
17. Stroncek DF, Vercellotti GM, Hammerschmidt DE, et al. Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis. Blood 1992;80:241-8.
18. Stroncek DF, Skubitz KM, Plachta LB, et al. Alloimmune neonatal neutropenia due to an antibody to the neutrophil Fc-gamma receptor III with maternal deficiency at CD16 antigen. Blood 1991;77:1572-80.
19. Lomax KJ, Leto TL, Nunoi H, et al. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 1989;245:409-12.
20. Leto TL, Lomax KJ, Volpp BD, et al. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science 1990;248:727-30.
21. 558: the flavin-binding component of the phagocyte NADPH oxidase. Science 1992;256:1459-62.
22. Clark RA, Malech HL, Gallin JI, et al. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med 1989;321:647-52.
23. Huizinga TW, Kleijer M, Tetteroo PA, et al. Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc-γ-receptor III (CD16). Blood 1990;75:213-7.
24. 2 family recognized by human leukocyte alloantisera. Blood 1996;88:1350-8.
25. Stroncek DF, Skubitz KM, McCullough JJ. Biochemical characterization of the neutrophil-specific antigen NB1. Blood 1990;75:744-55.
26. Springer TA, Anderson DC. Antibodies specific for the Mac-1, LFA-I, p 150, 95 glycoproteins or their family or for other granulocyte proteins. In: Reinherz EL, Haynes BJ, Nadler LM, Berstein ID, eds. Leukocyte typing II: human myeloid and hematopoietic cells. The 2nd International Workshop on Human Leukocyte Differentiation Antigens. Berlin: Springer-Verlag, 1986:55-68.
27. Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood 1991;77:673-86.
28. Stroncek DF, Shapiro RS, Filipovich AH, et al. Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NBI following marrow transplantation. Transfusion 1993;33:158-63.
29. Kline WE, Press C, Clay M, et al. Three sera defining a new granulocyte-monocyte-T-lymphocyte antigen. Vox Sang 1986;50:181-6.
30. Huizinga TW, Kuijpers RW, Kleijer M, et al. Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood 1990;76:1927-32.
31. Stroncek DF, Skubitz KM, Plachta LB, et al. Alloimmune neonatal neutropenia due to an antibody to the neutrophil Fcγ-receptor III with maternal deficiency of CD16 antigen. Blood 1991;77:1572-80.
32. Arnaout MA, Pitt J, Cohen HJ, et al. Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med 1982;306:693-9.
33. Dana N, Todd RF 3d, Pitt J, et al. Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest 1984;73:153-9.